Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Oct;35(3):449-459.
doi: 10.1016/j.bpa.2021.02.004. Epub 2021 Mar 2.

COVID-19 impact on the renal system: Pathophysiology and clinical outcomes

Affiliations
Review

COVID-19 impact on the renal system: Pathophysiology and clinical outcomes

Alan D Kaye et al. Best Pract Res Clin Anaesthesiol. 2021 Oct.

Abstract

Coronavirus disease (COVID-19) causes many deleterious effects throughout the body. Prior studies show that the incidence of acute kidney injury in COVID-19 patients could be as high as 25%. There are also autopsy reports showing evidence of viral tropism to the renal system. In this regard, COVID-19 can damage the kidneys and increase a patient's risk of requiring dialysis. Available evidence suggests that renal involvement in COVID-19 infection is not uncommon, and there has been an increased incidence of chronic kidney disease related to the pandemic. In this literature analysis, we address COVID-19 and its effects on the renal system, including the pathophysiologic mechanisms. We also address current studies on the causes of injury to the renal system, the cause of kidney failure, its effect on mortality, the impact on dialysis patients, and the impact on renal transplant patients. COVID-19 disease may have unique features in individuals on chronic dialysis and kidney transplant recipients, requiring increased vigilance in limiting viral transmission in perioperative, in-patient, and dialysis center settings.

Keywords: COVID-19; coronavirus; dialysis; injury; kidney; outcomes; renal.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest Richard Urman reports unrelated research funding from AcelRx and fees from Medtronic, Merck, Pfizer, Heron, and Takeda. Alan Kaye reports fees from Merck. Other authors report no conflicts of interest.

References

    1. Meena P., Bhargava V., Rana D.S., et al. COVID-19 and the kidney: a matter of concern. Curr Med Res Prac. 2020 Jul;10(4):165–168. doi: 10.1016/j.cmrp.2020.07.003. S2352081720300878. - DOI - PMC - PubMed
    1. Benedetti C., Waldman M., Zaza G., et al. COVID-19 and the kidneys: an update. Front Med. 2020 Jul 21;7:423. - PMC - PubMed
    1. Patel S.K., Singh R., Rana J., et al. The kidney and COVID-19 patients – important considerations. Trav Med Infect Dis. 2020 Sep;37:101831. - PMC - PubMed
    1. Batlle D., Soler M.J., Sparks M.A., et al. Acute kidney injury in COVID-19: emerging evidence of a distinct pathophysiology. JASN (J Am Soc Nephrol) 2020 Jul 1;31(7):1380–1383. - PMC - PubMed
    1. Benedetti C., Waldman M., Zaza G., et al. COVID-19 and the kidneys: an update. Front Med. 2020;7(423) doi: 10.3389/fmed.2020.00423. https://www.frontiersin.org/articles/10.3389/fmed.2020.00423/full [Internet] [cited 2021 Jan 21];7. Available from: - DOI - PMC - PubMed

LinkOut - more resources